These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 2242316

  • 21. Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulosclerosis in chronic aminonucleoside nephrosis.
    Hirano T, Morohoshi T.
    Nephron; 1992; 60(4):443-7. PubMed ID: 1584321
    [Abstract] [Full Text] [Related]

  • 22. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
    Kutyrina IM, Tareeva IE, Shestakova MV, Gerasimenko OI, Zverev KV, Rogov VA, Sheremet'eva OV.
    Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of captopril treatment in children with steroid-resistant nephrotic syndrome.
    Sözüer DT, Emre S, Tanman F, Sirin A, Nayir A, Uysal V.
    Acta Paediatr Jpn; 1994 Dec; 36(6):658-61. PubMed ID: 7871977
    [Abstract] [Full Text] [Related]

  • 24. Failure of angiotensin converting enzyme inhibition to affect the course of chronic puromycin aminonucleoside nephropathy.
    Marinides GN, Groggel GC, Cohen AH, Cook T, Baranowski RL, Westenfelder C, Border WA.
    Am J Pathol; 1987 Nov; 129(2):394-401. PubMed ID: 2823616
    [Abstract] [Full Text] [Related]

  • 25. Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.
    Wilmer WA, Hebert LA, Lewis EJ, Rohde RD, Whittier F, Cattran D, Levey AS, Lewis JB, Spitalewitz S, Blumenthal S, Bain RP.
    Am J Kidney Dis; 1999 Aug; 34(2):308-14. PubMed ID: 10430979
    [Abstract] [Full Text] [Related]

  • 26. Renal effects of captopril, indomethacin and nifedipine in nephrotic patients after an oral protein load.
    Garini G, Mazzi A, Buzio C, Mutti A, Allegri L, Savazzi G, Borghetti A.
    Nephrol Dial Transplant; 1996 Apr; 11(4):628-34. PubMed ID: 8671850
    [Abstract] [Full Text] [Related]

  • 27. Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome.
    Anderson S, Diamond JR, Karnovsky MJ, Brenner BM.
    J Clin Invest; 1988 Nov; 82(5):1757-68. PubMed ID: 2846658
    [Abstract] [Full Text] [Related]

  • 28. The changing face of childhood nephrotic syndrome.
    Chesney R.
    Kidney Int; 2004 Sep; 66(3):1294-302. PubMed ID: 15327442
    [No Abstract] [Full Text] [Related]

  • 29. The effect of recombinant human insulin-like growth factor-I on chronic puromycin aminonucleoside nephropathy in rats.
    Trachtman H, Maesaka J, Futterweit S, Ma C, Valderrama E, Chan JC, Chan W.
    Pediatr Res; 1996 Jan; 39(1):13-19. PubMed ID: 8825380
    [Abstract] [Full Text] [Related]

  • 30. The renal clearance of dextran sulfate decreases in puromycin aminonucleoside-induced glomerulosclerosis: a puzzle observation.
    Santos AM, Pomin VH, Stelling MP, Guimarães MA, Cardoso LR, Mourão PA.
    Clin Chim Acta; 2007 Aug; 383(1-2):116-25. PubMed ID: 17599817
    [Abstract] [Full Text] [Related]

  • 31. The effect of protamine on proteinuria and glomerular sclerosis in aminonucleoside nephropathy.
    Saito T, Yamakage K, Kurosawa K, Kyogoku Y, Furuyama T, Yoshinaga K.
    Tohoku J Exp Med; 1982 Apr; 136(4):461-2. PubMed ID: 7101279
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease.
    Masunaga Y, Tabei K, Takeda S, Ando Y, Kusano E, Asano Y.
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):961-6. PubMed ID: 8255007
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
    Thöne-Reinke C, Simon K, Richter CM, Godes M, Neumayer HH, Thormählen D, Hocher B.
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365
    [Abstract] [Full Text] [Related]

  • 37. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH, Nagalla S, Ballas SK.
    Cochrane Database Syst Rev; 2013 Mar 28; (3):CD009191. PubMed ID: 23543572
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Captopril, but not diltiazem, favorably affects the course of early chronic renal disease in rats.
    Podjarny E, Rathaus M, Bernheim J, Shapira J, Kariv N, Pomeranz A, Zadok S, Bernheim J.
    Nephron; 1990 Mar 28; 55(2):196-202. PubMed ID: 2256977
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.